Raphas Co., Ltd.
- Biotech or pharma, therapeutic R&D
RAPHAS is a South Korea-based biotech company specializing in proprietary microneedle technology for transdermal delivery of drugs and vaccines. Our platform enables minimally invasive, painless administration of biologics-including peptides (e.g., GLP-1), allergens, and nucleic acids (DNA, mRNA)-with proven room-temperature stability and preserved immunogenicity in preclinical studies. We are advancing pipeline programs such as GLP-1-loaded microneedles for metabolic disorders, dust mite allergen microneedles for immunotherapy, and innovative microneedle vaccine patches. RAPHAS is actively seeking partners for co-development, product commercialization, and licensing to accelerate the global launch of microneedle-based therapies and vaccine patches. Our versatile platform supports combination therapies, self-administration, and regulatory flexibility for both drug-device and standalone biologic products.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}